Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GS.5NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
GS.5NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-2584.54Japan
GS.5NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
GS.5NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
GS.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GS.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GS.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GS.5NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-24833US
CR.1NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17926.1China
CR.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
CR.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-18184Thailand
CR.1NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4270.22Thailand
CR.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
CR.1NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
CR.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CR.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CR.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
CR.1NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
CR.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
CR.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CR.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
CR.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
CR.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CR.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-21584South Korea
CR.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
CR.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
CR.1NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
CR.1NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
CR.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CR.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CR.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CR.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BV.2NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17926.1China
BV.2NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
BV.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-18184Thailand
BV.2NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4270.22Thailand
BV.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BV.2NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
BV.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BV.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BV.2NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
BV.2NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
BV.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BV.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BV.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BV.2NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BV.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BV.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BV.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BV.2NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used